This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Nao Yoneki: Innovator in Immunosuppressant Technology
Introduction
Nao Yoneki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunosuppressants, particularly through his innovative work on polymer derivatives. His research aims to enhance the effectiveness and safety of existing treatments.
Latest Patents
Yoneki holds a patent for a polymer derivative of macrolide immunosuppressant. The objective of this invention is to create a preparation that demonstrates improved effectiveness and safety compared to tacrolimus. This new formulation maintains a constant concentration in the blood, eliminating the need for adjustments based on individual blood kinetics. The invention involves a polymeric derivative of tacrolimus, where a polyethylene glycol segment is bonded to side-chain carboxy groups of a polyaspartic acid derivative.
Career Highlights
Nao Yoneki is associated with Nippon Kayaku Kabushiki Kaisha, a leading company in the pharmaceutical industry. His work has been pivotal in advancing immunosuppressant therapies, contributing to better patient outcomes.
Collaborations
Yoneki has collaborated with notable colleagues, including Akihiro Sekiguchi and Junpei Konno. Their combined expertise has fostered innovation in the field of immunosuppressants.
Conclusion
Nao Yoneki's contributions to immunosuppressant technology highlight his role as a key inventor in the pharmaceutical industry. His innovative approaches continue to pave the way for safer and more effective treatments.